There might be a problem with that dividend idea. FINRA wasn't too excited about the dividends and their review was part of the delay in getting that piece completed. I doubt Joe is going to slow down anything having to do with NGIO's IPO anymore than absolutely necessary. Assuming he did agree to do the dividend, how would he decide who gets the additional shares and who doesn't? In my opinion, if anybody should get more NGIO shares it should be those who were shareholders (and still are) before Jan of 2017. We are the "real" loyal shareholders. Plus we are the ones who have suffered as the result of the years long spin off and trading delay. I'm guessing most are still underwater from holding through the old regime and reverse spilt.
(4)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links